James George Chopas, VP/Chief Accounting Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 783 shares at $28.70 ($22K) on 2025-01-13, disclosed to the SEC on 2025-01-14.
Open-market sale of $22k APLS by VP/Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| APLS | SELL | 2026-01-15 | $19K | — | Filing → |
| APLS | SELL | 2025-09-17 | $5K | — | Filing → |
| APLS | SELL | 2025-09-03 | $15K | — | Filing → |